Next Article in Journal
Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mice
Previous Article in Journal / Special Issue
Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics
Article Menu

Export Article

Open AccessMeeting Report
Vaccines 2017, 5(4), 46; doi:10.3390/vaccines5040046

Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims

1
Animal Health Trust (AHT), Lanwades Park, Kentford, Newmarket, Suffolk CB8 7UU, UK
2
BIOTARGEN EA 7450, Normandie Université, UNICAEN—LABÉO, 14280 Saint Contest, France
3
RESPE (Réseau d’Epidémio-Surveillance en Pathologie Équine), 14280 Saint Contest, France
4
Clinique Vétérinaire de la Côte Fleurie, Route de Paris—Bonneville sur Touques, 14800 Deauville, France
*
Author to whom correspondence should be addressed.
Academic Editor: Alexander Zakhartchouk
Received: 24 October 2017 / Revised: 15 November 2017 / Accepted: 29 November 2017 / Published: 4 December 2017
View Full-Text   |   Download PDF [1935 KB, uploaded 4 December 2017]   |  

Abstract

To date, vaccination is one of the most efficient methods of prevention against equine infectious diseases. The vaccinology session, which was organised during the annual meeting of the French Equine Veterinarians Association (AVEF) at Reims (France) in 2016, aimed to approach three subjects of importance for the equine industry. Vaccination against three major equine diseases were used as examples: equine influenza (equine influenza virus), rhinopneumonitis (equine herpes virus 1/4), and tetanus (Clostridium tetani neuro-toxin). (1) Emergency vaccination: while it has been very successful to reduce the impact of equine influenza epizooties and it is also recommended for tetanus in case of surgery and accident, the benefit of emergency vaccination against equine herpes virus 1/4 remains arguable; (2) Compatibility of equine vaccines from different brands: despite being a frequent concerns for equine veterinarians, little information is available about the compatibility of equine vaccines from different commercial origins. The consequence of mixing different equine vaccines targeting the same disease is believed to be limited but scientific evidences are sparse; and, (3) Laps vaccination and vaccine shortage: they could have serious consequences in terms of protection and their impact should be evaluated on a case by case basis, taking into account the risk of contact with the pathogen and the effect on herd immunity. View Full-Text
Keywords: vaccination; horse; outbreak; emergency vaccination; equine influenza; rhinopneumonitis; tetanus vaccination; horse; outbreak; emergency vaccination; equine influenza; rhinopneumonitis; tetanus
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Paillot, R.; Marcillaud Pitel, C.; D’Ablon, X.; Pronost, S. Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims. Vaccines 2017, 5, 46.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top